We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Reference Lab Analyzes Cancers From Patients

By HospiMedica staff writers
Posted on 28 Dec 2004
A specialty reference laboratory utilizes discoveries from the Human Genome Project to analyze cancers from individual patients.

Called the Molecular Profiling Institute Inc. More...
(MPI), the laboratory was formed by the Translational Genomics Research Institute (Tgen) and the International Genomics Consortium (IGC), all based in Phoenix (AZ, USA). MPI's first molecular profile program, called Target Now, is available to cancer patients for whom all standard therapies have failed. These patients can have their cancer sampled, profiled, and assessed to determine if one or more drug targets can be identified in their tumor tissue. MPI has formed a strategic partnership with AmeriPath, a leading U.S. anatomic pathology laboratory, whereby AmeriPath will use MPI for its advanced esoteric reference lab and provide assistance with co-marketing and sales.

MPI has also entered into an initial licensing agreement with Agendia (Amsterdam, The Netherlands), whereby MPI is the sole provider in the United States of MammaPrint, a microarray assay used to provide important prognostic information for women with early invasive breast cancer.

"By identifying the individual molecular profile of a person's cancer, MPI helps oncologists and pathologists to provide better customized therapeutic options for their patients,” noted Robert J. Penny, M.D., Ph.D., president and CEO of MPI.



Related Links:
Translational Genomics
International Genomics Research Inst.

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Rapid Sepsis Test
SeptiCyte RAPID
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.